MP
NRC icon

Mangrove Partners’s NRC Health Common Stock NRC Stock Holding History

Mangrove Partners’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$385K Buy
+22,649
New +$385K 0.03% 230

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.24B AUM 31.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Mangrove Partners's NRC Position: Q1 2026 in Review

Mangrove Partners opened a new position in NRC Health Common Stock (NRC) in Q1 2026: 22,649 shares worth $385K. The stake represents 0.03% of the portfolio and ranks #230 among its holdings.

121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Mangrove Partners held 22,649 shares of NRC Health Common Stock worth $385K as of Q1 2026.
  • NRC Health Common Stock was a new Mangrove Partners position in Q1 2026.
  • NRC Health Common Stock made up 0.03% of Mangrove Partners's portfolio in Q1 2026, its #230 holding.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Mangrove Partners's 13F filing for Q1 2026, filed 15 May 2026.